Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Four different CACNA1S missense mutations were detected in hypokalemic periodic paralysis and five KCNJ2 missense mutations in Andersen-Tawil syndrome.
|
29606556 |
2018 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The aim was to describe a novel phenotype associated with a CACNA1S variant at a site previously linked to hypokalemic periodic paralysis.
|
29193480 |
2018 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
While dominant CACNA1S mutations were previously linked to malignant hyperthermia susceptibility or hypokalemic periodic paralysis, our findings strengthen the importance of DHPR for perinatal muscle function in human.
|
28012042 |
2017 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
We used whole-exome next-generation sequencing to identify a mutation in the calcium channel, voltage-dependent, L type, alpha subunit gene (CACNA1S), R900S, which is a rare mutation associated with hypokalemic periodic paralysis.
|
26433613 |
2015 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A single base mutation from cytosine to guanine at site 1582 was identified in exon 11 of CACNA1S in one FHPP pedigree, resulting in an arginine to glycine (R528G) substitution.
|
26252573 |
2015 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Herein we report, for the first time, a case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis type I resulting from a novel dominant mutation in CACNA1S.
|
25430699 |
2014 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Cases were confirmed genetically (13 with an R528H mutation in CACNA1S, 1 an R669H mutation in SCN4A) or had a convincing clinical diagnosis of HypoPP (13 genetically undetermined) if reported prior to the availability of genetic testing.
|
25088161 |
2014 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
WES revealed a de novo non-synonymous mutation in exon 21 of the calcium channel gene CACNA1S that has been previously reported in a single patient as a rare cause of atypical hypokalemic periodic paralysis.
|
22901280 |
2013 |
Hypokalemic periodic paralysis
|
0.700 |
Biomarker
|
disease |
MGD |
A calcium channel mutant mouse model of hypokalemic periodic paralysis.
|
23187123 |
2012 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Sporadic periodic paralysis (SPP), the second leading cause of hypokalemic periodic paralysis (HPP) in Asia, has a presentation similar to that of familial periodic paralysis (FPP) and is caused by gene mutations in the calcium (Ca(2+)) (CACNA1S) and sodium (Na(+)) (SCN4A) channels of skeletal muscle.
|
21841462 |
2012 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
This study expanded the spectrum of CACNA1S mutations associated with HypoPP and demonstrated a gender difference in the penetrance of the disease.
|
21845430 |
2012 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Hypokalemic periodic paralysis (HypoPP) type 1 is an autosomal dominant disease caused by mutations in the Ca(V)1.1 calcium channel encoded by the CACNA1S gene.
|
21855088 |
2011 |
Hypokalemic periodic paralysis
|
0.700 |
Biomarker
|
disease |
BEFREE |
Work studying molecular mechanisms indicates that 90% of the known mutations causing hypokalaemic periodic paralysis (HypoPP) result in loss of positively charged arginine residues in the S4 segments of either SCN4A or CACNA1S, possibly creating a gating-pore current that may be important in the pathogenesis of HypoPP.
|
20634695 |
2010 |
Hypokalemic periodic paralysis
|
0.700 |
Biomarker
|
disease |
CTD_human |
Mutations in the CACNA1S gene, which encodes the alpha 1-subunit of the skeletal muscle L-type voltage-dependent calcium channel, have been reported to be mainly responsible for HOKPP.
|
19822448 |
2010 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Severe respiratory phenotype caused by a de novo Arg528Gly mutation in the CACNA1S gene in a patient with hypokalemic periodic paralysis.
|
19822448 |
2010 |
Hypokalemic periodic paralysis
|
0.700 |
Biomarker
|
disease |
BEFREE |
We undertook direct automated DNA sequencing of the S4 regions of CACNA1S and SCN4A in 83 cases of hypokalemic periodic paralysis.
|
19118277 |
2009 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
These results identify a new mutation in CACNA1S and expand the spectrum of CACNA1S mutations associated with HypoPP.
|
19779499 |
2009 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
The calcium channel gene CACNA1S showed a mutation encoding p.R528H, which has been related previously to HypoPP.
|
17587224 |
2008 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
A Polish three-generation family with HypoPP and mutation in CACNA1S (R1239G) has been investigated.
|
18229654 |
2007 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CACNA1S are known to account for the majority of cases of familial hypokalaemic periodic paralysis (HOKPP).
|
17223993 |
2007 |
Hypokalemic periodic paralysis
|
0.700 |
Biomarker
|
disease |
BEFREE |
Mutations in the skeletal muscle calcium (CACNA1S) and sodium channel (SCN4A) genes have been reported to be responsible for familial HOPP.
|
18162704 |
2007 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Hypokalaemic periodic paralysis due to the CACNA1S R1239H mutation in a large African family.
|
17418573 |
2007 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
A Polish three-generation family with HypoPP and mutation in CACNA1S (R1239G) has been investigated.
|
18229654 |
2007 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
BEFREE |
Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis.
|
15711422 |
2005 |
Hypokalemic periodic paralysis
|
0.700 |
GeneticVariation
|
disease |
LHGDN |
The skeletal muscle calcium channel alpha-subunit gene CACNA1S is a major disease-causing gene for HypoPP, however, only three specific HypoPP-causing mutations, Arg528His, Arg1,239His and Arg1,239Gly, have been identified in CACNA1S to date.
|
15726306 |
2005 |